What is the clinical evidence from this study?

Study design: Other. Population: heart failure.

What question did this study set out to answer?

To correct the title of a previous article on the role of alpha-7 nicotinic acetylcholine receptors in heart failure treatment.

April 17, 2026Open Access

Correction: Alpha-7 nicotinic acetylcholine receptor: targeting the interplay between inflammation, renin-angiotensin aldosterone system, and nervous system for the novel treatment of heart failure

Key Result

This article is a correction to fix a typographical error in the title of a previously published paper regarding the alpha-7 nicotinic acetylcholine receptor and heart failure.

Key Points

To correct the title of a previous article on the role of alpha-7 nicotinic acetylcholine receptors in heart failure treatment.
Correction of the title in question for clarity and accuracy.
No new data or experimental methods were introduced in this correction.
Confirmed the accurate title of the article without alterations in research content.

PICO

Population

heart failure

Abstract

Correction on: Swiderski J, Gadanec LK, Hearth S, Rowlands BD, Murphy AJ, Apostolopoulos V and Zulli A (2026) Alpha-7 nicotinic acetylcholine receptor: targeting the interplay between inflammation, renin-angiotensin aldosterone system, and nervous system for the novel treatment of heart failure. Front. Pharmacol. 17:1756039. doi: 10.3389/fphar.2026.1756039 Alpha-7 nicotinic acetylcholine receptor: targeting the interplay between inflammation, renin-angiotensin aldosterone system, and nervous system for the novel treatment of heart failureThe title of this article was erroneously given as: sAlpha-7 nicotinic acetylcholine receptor: targeting the interplay between inflammation, renin-angiotensin aldosterone system, and nervous system for the novel treatment of heart failure.The correct title of the article is: Alpha-7 nicotinic acetylcholine receptor: targeting the interplay between inflammation, renin-angiotensin aldosterone system, and nervous system for the novel treatment of heart failure.There should be no "s" at the start of "Alpha-7 nicotinic…"

Bookmark

View Full Paper

Bookmark

View Full Paper

Cite This Study

Swiderski et al. (Mon,) conducted a other in heart failure. This article is a correction to fix a typographical error in the title of a previously published paper regarding the alpha-7 nicotinic acetylcholine receptor and heart failure.

synapsesocial.com/papers/69e1cd6f5cdc762e9d856ec4 https://doi.org/https://doi.org/10.3389/fphar.2026.1841172